Found: 4
Select item for more details and to access through your institution.
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2319766, doi. 10.1001/jamanetworkopen.2023.19766
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 9, p. 1079, doi. 10.1001/jamaneurol.2020.2581
- By:
- Publication type:
- Article
Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 97, n. 1, p. 73, doi. 10.1007/s11060-009-9991-4
- By:
- Publication type:
- Article
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 381, doi. 10.1177/13524585231218149
- By:
- Publication type:
- Article